SCHEMBL13601265

SCHEMBL13601265

Cc1ccc(Cn2ncc3c(-c4ccn[nH]4)nc(N)nc32)cc1

nearest known ligand 0.64

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 17/20 0.64
ADORA1 P30542 15/20 0.64
HDAC1 Q13547 3/20 0.46
GAA P10253 1/20 0.43
ADORA3 P0DMS8 1/20 0.41
ADORA2B P29275 1/20 0.41
HSP90AA1 P07900 1/20 0.41
TRAP1 Q12931 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601285 0.83 ADORA2A (0.65) ADORA2AADORA1HDAC1ADORA3ADORA2B
SCHEMBL13601287 0.81 ADORA2A (0.66) ADORA2AADORA1HDAC1ADORA3ADORA2B
SCHEMBL13601273 0.78 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2BHSP90AA1
SCHEMBL4453248 0.78 ADORA2A (0.48) ADORA2AADORA1HDAC1GAAHSP90AA1
SCHEMBL13601278 0.77 ADORA2A (0.67) ADORA2AADORA1HDAC1ADORA3ADORA2B
SCHEMBL20118840 0.77 HSP90AA1 (0.63) ADORA2AADORA1HDAC1GAAHSP90AA1
SCHEMBL13601224 0.76 ADORA2A (0.81) ADORA2AADORA1HDAC1
SCHEMBL29031953 0.71 ADORA2A (0.52) ADORA2AADORA1HDAC1HSP90AA1TRAP1
SCHEMBL24437456 0.70 ADORA2A (0.70) ADORA2AADORA1HDAC1
SCHEMBL29031957 0.68 ADORA2A (0.69) ADORA2AADORA1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed
US-7629349-B2 Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists VERNALIS RESEARCH LIMITED (GB) 2009-12-08 US disclosed